Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
DISASTERS AVERTED — Near Miss Case Studies
TOP STORIES — Diabetes News and Research
How to Eliminate Carb Counting for Type 1 Pump Users
Is Metformin the Best Choice for Type 2 Diabetes Patients?
Metformin Lowers Mortality Risk for Patients who have Diabetes and Covid-19
MOST POPULAR ARTICLES OF THE MONTH
#1 How a Certain Virus Can Cause Diabetes
Letter from the Editor
It seems a little unfair that we often take our type 2 patients off oral medication when they begin basal/bolus insulin use, and it makes even less sense that we won’t give a type 1 patient anything but insulin. Over the past 3 years we have had many studies about the use of metformin, SGLT-2 inhibitors and GLP-1 agonists in type 1 patients. However, both AACE and the ADA have not been in favor of the use of these products with insulin.
This week we have a study from Brenda Oppong, PharmD Candidate, LECOM School of Pharmacy, that looks at the use of a SGLT-2 inhibitor to replace carb counting and in pump patients. The results of this study make a strong argument for adding this oral medicine to a patient with type 1 drug regimen. Check out what Brenda found in her research in our Laterpay feature.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
DISASTERS AVERTED — Near Miss Case Studies
A woman in her 60s, extremely insulin-sensitive with type 1 diabetes, came for a review of carb counting and blood sugar logs. Pt had been running blood sugars above the target range. When asking pt why she thought her blood sugars were running high, she stated she was fearful of having low blood sugars….
TOP STORIES — Diabetes News and Research
Could adding a SGLT-2 inhibitor to a closed-loop automated insulin delivery reduce the need for carbohydrate counting?
Metformin has been associated with a higher incidence of peripheral neuropathy.
Diabetes patients who were taking metformin before contracting Covid-19 had dramatically different outcomes.